LiyunYuanMDPhD
Gastroenterology • Los Angeles, CAHepatology & Liver Transplantation
Assistant Professor of Clinical Medicine at University of Southern California
Dr. Yuan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1520 San Pablo St
Ste 1000
Los Angeles, CA 90033Phone+1 323-442-5100Fax+1 323-442-5625
Education & Training
University of ColoradoFellowship, Transplant Hepatology, 2014 - 2015
University of Southern California/Los Angeles General Medical Center (USC/LA General)Fellowship, Gastroenterology, 2011 - 2014- University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Internal Medicine, 2009 - 2011
- University of Southern California/Los Angeles General Medical Center (USC/LA General)Internship, Internal Medicine, 2008 - 2009
University of Southern California PhD, Pharmaceutical Sciences, Krown Fellowship, 2002 - 2007
Hunan Medical UniversityClass of 1995
Certifications & Licensure
CA State Medical License 2010 - 2026
CO State Medical License 2014 - 2021- American Board of Internal Medicine Gastroenterology
- American Board of Internal Medicine Transplant Hepatology
Awards, Honors, & Recognition
- Rho Chi Membership
- Top Doctor in 2017 Pasadena Magazine
- top doctor pasadena magazine, 2020
- Join now to see all
Clinical Trials
- Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment Start of enrollment: 2015 Sep 22
- Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH) Start of enrollment: 2016 Mar 01
- Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis Start of enrollment: 2017 Aug 30
Publications & Presentations
PubMed
- 11 citationsNAFLD in Women: Unique Pathways, Biomarkers, and Therapeutic OpportunitiesLiyun Yuan, Ani Kardashian, Monika Sarkar
Current Hepatology Reports. 2019-11-18 - 21 citationsNonalcoholic Fatty Liver Disease: The Role of Visceral Adipose Tissue.Courtney L Hanlon, Liyun Yuan
Clinical Liver Disease. 2022-03-01 - 27 citationsReversible lipidization prolongs the pharmacological effect, plasma duration, and liver retention of octreotide.Liyun Yuan, Jeffrey Wang, Wei-Chiang Shen
Pharmaceutical Research. 2005-02-24
Journal Articles
- NAFLD in Women: Unique Pathways, Biomarkers, and Therapeutic OpportunitiesLiyun Yuan, Ani Kardashian & Monika Sarkar, Current Hepatology Reports volume 18, pages425–432(2019, 11/2019
- PNPLA3 and nonalcoholic fatty liver disease: towards personalized medicine for fatty liverLiyun Yuan, Norah A. Terrrault, Hepatobiliary Surgery and Nutrition, 2019, 2019
Press Mentions
Coffee May Reduce Liver Disease Severity in People with Type 2 DiabetesJanuary 12th, 2023- Missionary Headshrinkers in Gold Canyons: A Survivor’s PerspectiveFebruary 12th, 2021
Professional Memberships
- Member
- Member
- American Association for the Study of Liver Diseases (AASLD)Member
Other Languages
- Chinese (Mandarin)
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
